Berlin - Delayed Quote EUR

Cerus Corp (CU2.BE)

1.1780

+0.0160

+(1.38%)

At close: April 30 at 8:08:20 AM GMT+2

Cerus: Q1 Earnings Snapshot

CERS) on Thursday reported a loss of $7.7 million in its first quarter. On a per-share basis, the Concord, California-based company said it had a loss of 4 cents. The biomedical products company posted revenue of $43.2 million in the period.

Associated Press Finance 2 hours ago

CERS
Cerus Corporation Announces First Quarter 2025 Financial Results

CONCORD, Calif., May 01, 2025--Cerus Corporation (Nasdaq: CERS) announced today financial results for the first quarter ended March 31, 2025, and provided a business update.

Business Wire 2 hours ago

CERS
With 64% ownership, Cerus Corporation (NASDAQ:CERS) boasts of strong institutional backing

Key Insights Institutions' substantial holdings in Cerus implies that they have significant influence over the...

Simply Wall St. 11 hours ago

CERS
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

CONCORD, Calif., April 17, 2025--Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2025 financial results will be released on Thursday, May 1, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.

Business Wire 14 days ago

CERS
Cerus Leads Our Selection Of 3 Promising Penny Stocks

As U.S. stocks attempt to recover from recent downturns, with the S&P 500 and Nasdaq aiming to end their losing streaks, investors are navigating a market filled with uncertainty yet ripe with potential opportunities. Penny stocks, though often overlooked in favor of more established names, remain an intriguing investment area for those seeking growth in smaller or newer companies. By focusing on firms with strong financial foundations and clear paths to growth, investors can uncover...

Simply Wall St. last month

NVTS

RSKD

CERS
Are Investors Undervaluing Cerus Corporation (NASDAQ:CERS) By 49%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Cerus fair value estimate is US$2.99 Current share price of...

Simply Wall St. last month

CERS
Cerus secures CE mark approval for LED-based illumination device

Cerus states that the CE mark represents the first regulatory approval for its “next generation” illuminator.

Medical Device Network last month

CERS
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

CONCORD, Calif., March 05, 2025--Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood System for platelets and plasma under the European Union (EU) Medical Device Regulation (MDR). This approval allows Cerus to market the INT200 throughout the EU and in other regions that recognize the CE mark. Some countries may require additional in-country regulatory approval prior to commercializatio

Business Wire last month

CERS
Cerus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Cerus ( NASDAQ:CERS ) Full Year 2024 Results Key Financial Results Revenue: US$180.3m (up 15% from FY 2023). Net loss...

Simply Wall St. 2 months ago

CERS
Cerus Corp (CERS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow

Cerus Corp (CERS) reports a 15% increase in annual product revenue and achieves positive adjusted EBITDA, despite challenges in foreign exchange and gross margins.

GuruFocus.com 2 months ago

CERS
Cerus: Q4 Earnings Snapshot

CERS) on Thursday reported a loss of $2.5 million in its fourth quarter. On a per-share basis, the Concord, California-based company said it had a loss of 1 cent. The biomedical products company posted revenue of $50.8 million in the period.

Associated Press Finance 2 months ago

CERS
Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

CONCORD, Calif., February 20, 2025--Cerus Corporation (Nasdaq: CERS) today announced financial results for its full year and fourth quarter ended December 31, 2024.

Business Wire 2 months ago

CERS
Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

CONCORD, Calif., February 19, 2025--Cerus Corporation (Nasdaq: CERS) announced today that members of Cerus’ management are scheduled to present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, at 11:10 a.m. EST.

Business Wire 2 months ago

CERS
US Penny Stocks To Watch In February 2025

As the S&P 500 hovers near record highs and treasury yields drop following retail sales data, investors are keeping a close eye on the broader U.S. market trends. Penny stocks, often associated with smaller or newer companies, remain an intriguing investment area despite their vintage name. These stocks can offer a blend of affordability and growth potential when backed by solid financials, making them worth considering for those seeking opportunities in this unique segment of the market.

Simply Wall St. 2 months ago

EDSA

FRGE

CERS
Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

CONCORD, Calif., February 07, 2025--Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full-year 2024 financial results will be released on Thursday, February 20, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.

Business Wire 2 months ago

CERS
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update

CONCORD, Calif., January 13, 2025--Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2024 and provided product revenue guidance for full-year 2025.

Business Wire 3 months ago

CERS
Cerus And 2 Other US Penny Stocks With Promising Potential

The U.S. stock market has recently experienced a surge, with major indexes like the Dow Jones and Nasdaq showing significant gains, driven by strong performances in technology stocks and a notable rise in Bitcoin. Amidst this backdrop, penny stocks continue to capture investor interest as they offer unique opportunities for growth at lower price points. Though often associated with smaller or newer companies, these stocks can present substantial potential when backed by solid financials and...

Simply Wall St. 3 months ago

CERS

DC

DC-WT
Cerus And 2 Other US Penny Stocks To Watch

The U.S. stock market recently experienced a stumble, particularly in technology shares, as investors assessed earnings reports and economic data amidst fluctuating interest rates and inflation expectations. In such a climate, the appeal of penny stocks remains significant for those seeking affordable entry points with potential growth prospects. While the term "penny stocks" may seem outdated, these typically smaller or newer companies can offer unique opportunities when supported by strong...

Simply Wall St. 4 months ago

CERS

CVAC

CLOV
Cerus Corporation to Participate in Upcoming Investor Conferences

CONCORD, Calif., November 13, 2024--Cerus Corporation (Nasdaq: CERS) announced management participation in two upcoming investor conferences.

Business Wire 5 months ago

CERS
Cerus Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Cerus ( NASDAQ:CERS ) Third Quarter 2024 Results Key Financial Results Revenue: US$46.0m (up 16% from 3Q 2023). Net...

Simply Wall St. 5 months ago

CERS

Performance Overview

Return	CU2.BE	S&P 500 (^GSPC)
YTD	-19.86%	-4.72%
1-Year	-26.88%	+11.67%
3-Year	-73.23%	+35.63%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Cerus Corp (CU2.BE)

Cerus: Q1 Earnings Snapshot

Cerus Corporation Announces First Quarter 2025 Financial Results

With 64% ownership, Cerus Corporation (NASDAQ:CERS) boasts of strong institutional backing

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

Cerus Leads Our Selection Of 3 Promising Penny Stocks

Are Investors Undervaluing Cerus Corporation (NASDAQ:CERS) By 49%?

Cerus secures CE mark approval for LED-based illumination device

Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

Cerus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Cerus Corp (CERS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow

Cerus: Q4 Earnings Snapshot

Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

US Penny Stocks To Watch In February 2025

Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update

Cerus And 2 Other US Penny Stocks With Promising Potential

Cerus And 2 Other US Penny Stocks To Watch

Cerus Corporation to Participate in Upcoming Investor Conferences

Cerus Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Performance Overview